Clone of Updates and Challenging Cases in Pediatric Neuroblastoma and Wilms Tumor
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
Updates and Challenging Cases in Pediatric Neuroblastoma and Wilms Tumor
Updates in the treatment of pediatric neuroblastoma and Wilms Tumor are presented, highlighting recent practice-changing publications and evolving study questions.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00

Pages